Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Vanderbilt University National Cancer Institute (NCI) H. Lee Moffitt Cancer Center and Research Institute Kentuckiana Cancer Institute Emory University University of Alabama at Birmingham |
---|---|
Information provided by: | Vanderbilt University |
ClinicalTrials.gov Identifier: | NCT00592865 |
Study Objective:
Brain tumors are poorly understood. The purpose of this research is to examine whether factors in lifestyle play a role in brain tumor development. The study will also investigate the contribution of inherited susceptibility to the risk of brain cancer. By gaining a better understanding of these influences, the investigators hope to learn how to prevent brain tumors in future generations, and to develop more effective strategies for treatment.
Study Protocol:
This is a case-control investigation. Persons affected with a brain tumor are compared to unaffected persons on previous medical history, diet and other factors. Those enrolled in the study will participate in an interview on general background, diet, medical history and lifestyle, and will provide a sample of DNA, clippings of your toenails, and a tap water sample from your home. All procedures are performed in the clinic or through the mail.
'Cases': Cases eligible for the study are persons with a recent diagnosis of a primary brain tumor (glioma or meningioma), at least 18 years of age.
'Controls': Controls in the study are non-family members of patients, similar in age and of the same gender. Suitable controls include in-laws, friends, neighbors and co-workers.
Condition |
---|
Brain Neoplasm, Primary Brain Neoplasms, Malignant Brain Neoplasms, Benign |
Study Type: | Observational |
Official Title: | Genetic Epidemiology of Adult Brain Tumors |
Mouthwash and salvia samples. Toenail samples are also collected.
Estimated Enrollment: | 750 |
Study Start Date: | October 2003 |
Estimated Study Completion Date: | July 2012 |
Estimated Primary Completion Date: | July 2012 (Final data collection date for primary outcome measure) |
Primary Objective:
The primary objective of this research is to establish a clinic-based case-control study for examination of potential risk factors for primary adult brain tumors. After assembling a series of 1,500 cases and 3,000 controls, investigators will test current hypotheses on ge-netic and environmental risk factors for the occurrence of these tumors.
STUDY DESIGN:
In this case-control study, persons with a recent diagnosis (within 4 months) of a primary brain tumor will be identified in the neurology/neurosurgery clinics at major treatment referral centers in the Southeast. Non-blood related relatives (eg. in-laws), friends or other persons will be recruited as controls. Names and contact information of eligible controls will be ascertained from patients. A total of 1,500 cases and 3,000 controls will be enrolled over the course of the 5-year study. All enrolled subjects will complete a one hour interview on lifestyle, environmental exposures, diet, physical activity, tobacco use and medical history. They will also be asked to provide a DNA sample, a water sample and a toenail sample (from each great toe). At the end of data collection, lifestyles and genetic attributes will be compared in cases and controls to identify any differences that may be relevant to the causation of disease. Because the study will recruit patients near the time of disease diagnosis, full enrollment should be possible. In addition, high re-sponse rates are anticipated among the controls. Thus, with the large numbers of patients available and high anticipated response rates, the study offers a unique opportunity to successfully identify environmental and genetic risk factors for this uncommon form of cancer.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
"Case" subjects will be identified from the patients referred to neurology/neurosurgery clinics. Cases, when enrolled in the study, will be asked to identify potential "controls" by providing the name and phone number of the same-sex in-law nearest in age to the case and/or the name of a same-sex friend will also be sought.
Inclusion Criteria:
United States, Alabama | |
University of Alabama at Birmingham | |
Birmingham, Alabama, United States, 35294 | |
United States, Florida | |
H. Lee Moffitt Cancer Center | |
Tampa, Florida, United States, 33612 | |
United States, Georgia | |
Emory University | |
Atlanta, Georgia, United States, 30322 | |
United States, Kentucky | |
Kentuckaina Cancer Institute | |
Louisville, Kentucky, United States, 40202 | |
United States, Tennessee | |
Vanderbilt University Medical Center, Department of Neurological Surgery | |
Nashville, Tennessee, United States, 37232 |
Principal Investigator: | Kathleen M. Egan, DSc | H. Lee Moffitt Cancer Center |
Principal Investigator: | Reid C. Thompson, MD | Vanderbilt University |
Principal Investigator: | Renato V. LaRocca, MD | Kentuckiana Cancer Center |
Principal Investigator: | Jeffrey Olson, MD | Emory University |
Principal Investigator: | Burt Nabors, MD | University of Alabama at Birmingham |
Responsible Party: | Moffitt Cancer Center ( Kathleen Egan, DSC ) |
Study ID Numbers: | 030917 |
Study First Received: | January 7, 2008 |
Last Updated: | January 11, 2008 |
ClinicalTrials.gov Identifier: | NCT00592865 History of Changes |
Health Authority: | United States: Institutional Review Board |
Brain Neoplasms Central Nervous System Diseases Central Nervous System Neoplasms Brain Diseases Nervous System Neoplasms |
Brain Neoplasms Neoplasms Neoplasms by Site Nervous System Diseases |
Central Nervous System Diseases Central Nervous System Neoplasms Brain Diseases Nervous System Neoplasms |